Clinical Trial Update: Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of oral gepotidacin in uncomplicated urinary tract infection (acute cystitis) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis
• Urinary Tract Infection

Drugs mentioned

• Gepotidacin (gepotidacin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 2 | Status: COMPLETED | Results posted: 2020-01-07